Ryman Healthcare Limited Stock Performance
| RHCGF Stock | USD 2.61 0.27 9.38% |
The company holds a Beta of 0.19, which implies not very significant fluctuations relative to the market. As returns on the market increase, Ryman Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Ryman Healthcare is expected to be smaller as well. At this point, Ryman Healthcare has a negative expected return of -0.1%. Please make sure to check Ryman Healthcare's skewness, as well as the relationship between the rate of daily change and price action indicator , to decide if Ryman Healthcare performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Ryman Healthcare Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's technical and fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
| Begin Period Cash Flow | 20.2 M | |
| Total Cashflows From Investing Activities | -787.3 M | |
| Free Cash Flow | 287.3 M |
Ryman |
Ryman Healthcare Relative Risk vs. Return Landscape
If you would invest 282.00 in Ryman Healthcare Limited on September 2, 2024 and sell it today you would lose (21.00) from holding Ryman Healthcare Limited or give up 7.45% of portfolio value over 90 days. Ryman Healthcare Limited is currently producing negative expected returns and takes up 1.921% volatility of returns over 90 trading days. Put another way, 17% of traded pink sheets are less volatile than Ryman, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Ryman Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ryman Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Ryman Healthcare Limited, and traders can use it to determine the average amount a Ryman Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0524
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RHCGF |
Estimated Market Risk
| 1.92 actual daily | 17 83% of assets are more volatile |
Expected Return
| -0.1 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ryman Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ryman Healthcare by adding Ryman Healthcare to a well-diversified portfolio.
Ryman Healthcare Fundamentals Growth
Ryman Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ryman Healthcare, and Ryman Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ryman Pink Sheet performance.
| Return On Equity | 0.18 | |||
| Return On Asset | -7.0E-4 | |||
| Profit Margin | 1.13 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 4.01 B | |||
| Shares Outstanding | 500 M | |||
| Price To Earning | 11.98 X | |||
| Price To Book | 1.08 X | |||
| Price To Sales | 4.64 X | |||
| Revenue | 503.76 M | |||
| EBITDA | 788.44 M | |||
| Cash And Equivalents | 47.88 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 2.58 B | |||
| Debt To Equity | 0.76 % | |||
| Book Value Per Share | 7.26 X | |||
| Cash Flow From Operations | 585.98 M | |||
| Earnings Per Share | 0.77 X | |||
| Total Asset | 10.97 B | |||
| Retained Earnings | 1.28 B | |||
| Current Asset | 221 M | |||
| Current Liabilities | 107 M | |||
About Ryman Healthcare Performance
By analyzing Ryman Healthcare's fundamental ratios, stakeholders can gain valuable insights into Ryman Healthcare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ryman Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ryman Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company was founded in 1984 and is based in Christchurch, New Zealand. Ryman Healthcare operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 6700 people.Things to note about Ryman Healthcare performance evaluation
Checking the ongoing alerts about Ryman Healthcare for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ryman Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ryman Healthcare generated a negative expected return over the last 90 days | |
| Ryman Healthcare Limited has accumulated 2.58 B in total debt with debt to equity ratio (D/E) of 0.76, which is about average as compared to similar companies. Ryman Healthcare has a current ratio of 0.7, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Ryman Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Ryman Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ryman Healthcare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ryman to invest in growth at high rates of return. When we think about Ryman Healthcare's use of debt, we should always consider it together with cash and equity. | |
| About 17.0% of Ryman Healthcare outstanding shares are owned by corporate insiders |
- Analyzing Ryman Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ryman Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Ryman Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ryman Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ryman Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ryman Healthcare's pink sheet. These opinions can provide insight into Ryman Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Ryman Pink Sheet analysis
When running Ryman Healthcare's price analysis, check to measure Ryman Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ryman Healthcare is operating at the current time. Most of Ryman Healthcare's value examination focuses on studying past and present price action to predict the probability of Ryman Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ryman Healthcare's price. Additionally, you may evaluate how the addition of Ryman Healthcare to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |